GS
TEVA icon

GTS Securities’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

GTS Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-116,900
Closed -$2.11M – 3815
2024
Q3 		$2.11M Sell
116,900
-18,700
-14% -$327K ﹤0.01% 1543
2024
Q2 		$2.2M Sell
135,600
-248,900
-65% -$3.83M ﹤0.01% 1426
2024
Q1 		$5.43M Buy
384,500
+41,300
+12% +$521K 0.01% 811
2023
Q4 		$3.58M Buy
343,200
+107,900
+46% +$1.01M 0.01% 1231
2023
Q3 		$2.4M Buy
+235,300
New +$2.19M ﹤0.01% 1399

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

GTS Securities's TEVA Position: Q2 2026 in Review

GTS Securities sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026, closing a stake of 46,218 shares — an estimated $1.39M sold.

GTS Securities first reported a position in TEVA in Q2 2023 and held it in 10 quarters. The position peaked at $14.5M in Q1 2024. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • GTS Securities reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 46,218 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $1.39M.
  • GTS Securities first reported a position in Teva Pharmaceutical Industries Limited in Q2 2023 and held it in 10 quarters.
  • GTS Securities's Teva Pharmaceutical Industries Limited position peaked at $14.5M in Q1 2024.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.